Your browser doesn't support javascript.
Granulomatosis with Polyangiitis Following Pfizer-BioNTech COVID-19 Vaccination.
Shirai, Tsuyoshi; Suzuki, Jun; Kuniyoshi, Shimpei; Tanno, Yuito; Fujii, Hiroshi.
  • Shirai T; Department of Rheumatology, Tohoku University Hospital, Miyagi, Japan.
  • Suzuki J; Department of Otolaryngology, Head and Neck Surgery, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Kuniyoshi S; Department of Pathology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Tanno Y; Department of Rheumatology, Tohoku University Hospital, Miyagi, Japan.
  • Fujii H; Department of Rheumatology, Tohoku University Hospital, Miyagi, Japan.
Mod Rheumatol Case Rep ; 2022 Mar 04.
Article in English | MEDLINE | ID: covidwho-20242886
ABSTRACT
We report the first case of proteinase 3 (PR3)- antineutrophil cytoplasmic antibody (ANCA)-positive granulomatosis with polyangiitis (GPA) with predominant ears, nose, and throat (ENT) manifestations following COVID-19 vaccination. A 63-year-old woman presented with aural fullness three days after vaccination. She presented with progressive rhinosinusitis and otitis media leading to profound hearing loss within three weeks. Clinical imaging revealed soft-tissue shadows in the paranasal sinuses with multiple pulmonary nodules, and histopathology was consistent with a diagnosis of GPA. It is crucial to be wary of the possibility of GPA in patients who received COVID-19 vaccines due to its rapid disease progression.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines Language: English Year: 2022 Document Type: Article Affiliation country: Mrcr

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines Language: English Year: 2022 Document Type: Article Affiliation country: Mrcr